Nichols Garrett

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$277,436.06

Insider Activity of Nichols Garrett

According to the SEC Form 4 filings, Nichols Garrett, being in a position of

  1. Chief Medical Officer at Candel Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 34579 shares for $192,226,
    over all time since 2024-07-11, has bought 0 shares, and sold 34579 shares for $192,226.

The largest sale of all time was on 2024-07-17 and amounted to 10875 shares of Candel Therapeutics, Inc. for $70,390.

Biography of Nichols Garrett

No biography is available at this moment.

2024-11-29SaleCandel Therapeutics, Inc.
CADL
Chief Medical Officer
13,935
0.0415%
$4.56$63,482+19.96%
2024-07-17SaleCandel Therapeutics, Inc.
CADL
Chief Medical Officer
10,875
0.036%
$6.47$70,390-9.06%
2024-07-11SaleCandel Therapeutics, Inc.
CADL
Chief Medical Officer
9,769
0.0343%
$5.97$58,3540%
2020-02-10SaleChimerix, Inc.
CMRX
Chief Medical Officer
8,805
0.0141%
$1.68$14,830+77.65%
2020-02-07SaleChimerix, Inc.
CMRX
Chief Medical Officer
2,550
0.0042%
$1.70$4,335+78.7%
2020-01-07SaleChimerix, Inc.
CMRX
Chief Medical Officer
30,680
0.0482%
$2.15$66,045+28.83%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.